Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
We review articles describing intravitreal injection of anti-VEGF drug trials, while discussing the mechanisms of the action of anti-VEGF antibodies, and also evaluating their outcomes. Intraocular injections of anti-VEGF drug are considered to be an effective treatment for macular edema after retin...
Saved in:
Main Authors: | Kenichi Kimoto, Toshiaki Kubota |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2012/852183 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
by: Toshiaki Kubota, et al.
Published: (2012-01-01) -
VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy
by: Caroline Hilmi, et al.
Published: (2012-01-01) -
Use of Anti-VEGF Agents in Glaucoma Surgery
by: Mark Slabaugh, et al.
Published: (2017-01-01) -
Human Platelets Take up Anti-VEGF Agents
by: B. Sobolewska, et al.
Published: (2021-01-01) -
Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
by: Selwyn M. Prea, et al.
Published: (2015-01-01)